Watch NVIDIA announce some big news tonight at 9pm ET via /r/gadgets http://ift.tt/21GTX1Y
FINALLY THE NEW LP! I’ve finally started Mass Effect 2! Let’s welcome back Commander Shepard and all the adventures we will have!
Hahaha good times!
Still one of the most difficult choices a Trainer can make…
Navigate your smartwatch by touching your skin via /r/gadgets http://ift.tt/1ZkUBjR
Harvard-made robot can teach kids how to code via /r/gadgets http://ift.tt/1WClMHX
HooliNerd zockt: THE BINDING OF ISAAC - DEBIRTH
One of the biggest criticisms of controversial blood-testing startup Theranos has been simple: Where’s the data?
We may finally know — at least as soon as this summer.
Theranos CEO Elizabeth Holmes is scheduled to present data on the company's proprietary blood test on August 1, 2016 in Philadelphia at the annual American Association for Clinical Chemistry conference.
This will be the first time Theranos has presented its data at a scientific conference according to the AACC, and it will include data on Theranos’ proprietary finger-prick test and small collection system.
The AACC is an organization of professionals in the clinical laboratory field, including physicians, researchers, and lab professionals.
“AACC members have been asking for this information, and we are thrilled that Ms. Holmes is presenting the science behind the technology for the first time at AACC, the premier scientific forum for laboratory medicine,” AACC CEO Janet B. Kreizman said in a news release.
Theranos board member David Boies told Bloomberg that some data will also be released before the start of the conference.
Theranos has come under fire over the last six months regarding the accuracy of its blood tests, particularly its finger-prick tests that only require a small amount of blood. Theranos has not publicly released any data on how well its tests work in comparison to standard blood tests, though in recent weeks the company has added a scientific advisory board tasked in part with finding ways to present data to the scientific community.
In the meantime, the company has been facing ongoing investigations by the SEC and the US Attorney’s Office, and it has stopped running tests out of its northern California laboratory until things with the Centers for Medicare and Medicaid, which has issued the company warning letters, is straightened out.
Theranos did not immediately respond to request for comment.
RELATED: Theranos just made a crucial move that could help its reputation
ALSO READ: US regulators want to bar Elizabeth Holmes from Theranos for 2 years
Join the conversation about this story »
NOW WATCH: This medical device should make drawing blood a lot less painful
SOSPENDO – The Best Wearable Support for Mobile Devices - http://thegadgetflow.com/portfolio/sospendo/
Monovision improves reaction times & accuracy simulating objects up-close in Virtual Reality
In a yet another example to integrate electronic devices with the human body, researchers from the University of Tokyo have developed an ultrathin, protective layer that will help create “electronic skin” displays of blood oxygen level, e-skin heart rate sensors for athletes and other applications.
The team demonstrated its use by creating an air-stable, organic light-emitting diode (OLED) display. Integrating electronic devices with the human body to enhance or restore body function for biomedical applications is the goal of researchers around the world. Wearable electronics, in particular, need to be thin and flexible to minimise impact where they attach to the body. However, most devices developed so far have required millimetre-scale thickness glass or plastic substrates with limited flexibility, while micrometer-scale thin flexible organic devices have not been stable enough to survive in air.
Keep reading
Let's go invent tomorrow instead of worrying about what happened yesterday. - Steve Jobs
272 posts